MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
7,173,853
Share change
-1,253,952
Total reported value
$6,599,409
Price per share
$0.92
Number of holders
30
Value change
-$807,474
Number of buys
7
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q3 2018

As of 30 Sep 2018, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,173,853 shares. The largest 10 holders included Vanguard Group Inc, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, IFP Advisors, Inc, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, ELEMENT CAPITAL MANAGEMENT LLC, Creative Planning, K.J. Harrison & Partners Inc, and NORTHERN TRUST CORP. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.